CD154 (the CD40 ligand) plays a role in anti-tumor activity and growth inhibitory effects in breast cancer33,34 and recent studies indicate that PTBP1 may stabilize CD154 mRNA via targeting its 3′-UTR21,22. This evidence concerns the gene CD40LG and neoplasm.